[类风湿关节炎患者对传统治疗难治时使用抗肿瘤坏死因子α制剂的情况] - Suppr | 超能文献

[Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].

作者信息

González-Gay Miguel A, Agudo Mario

出版信息

Med Clin (Barc). 2010 May 22;134(15):684-5. doi: 10.1016/j.medcli.2009.12.003. Epub 2010 Feb 21.

DOI:10.1016/j.medcli.2009.12.003

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].[类风湿关节炎患者对传统治疗难治时使用抗肿瘤坏死因子α制剂的情况]

Med Clin (Barc). 2010 May 22;134(15):684-5. doi: 10.1016/j.medcli.2009.12.003. Epub 2010 Feb 21.

2

Which TNF inhibitor for rheumatoid arthritis?哪种肿瘤坏死因子抑制剂用于治疗类风湿性关节炎？

Med Lett Drugs Ther. 2010 May 17;52(1338):38-9.

3

Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.接受抗TNF-α药物治疗的类风湿关节炎患者发生带状疱疹的风险。

JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146.

4

[Anti-TNF therapy in rheumatoid arthritis].[类风湿关节炎中的抗TNF治疗]

Nihon Rinsho Meneki Gakkai Kaishi. 2004 Feb;27(1):7-15. doi: 10.2177/jsci.27.7.

5

Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.类风湿关节炎患者使用抗肿瘤坏死因子治疗的持续性：来自 RADIUS 注册研究的观察结果。

J Rheumatol. 2011 Jul;38(7):1273-81. doi: 10.3899/jrheum.101142. Epub 2011 May 15.

6

[Should we be afraid of the anti-TNFalpha drugs in 2008?].2008年我们应该害怕抗肿瘤坏死因子α药物吗？

Rev Med Interne. 2008 Dec;29(12):971-4. doi: 10.1016/j.revmed.2008.04.022. Epub 2008 Jun 20.

7

Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.对伊亚诺内等人所著的《肿瘤坏死因子抑制剂的药物留存率：来自意大利国家注册库（GISEA注册库）的2003 - 2004年数据》的回应

Ann Rheum Dis. 2014 Jun;73(6):e32. doi: 10.1136/annrheumdis-2013-205037. Epub 2014 Mar 17.

8

Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.在管理式医疗人群中，类风湿关节炎肿瘤坏死因子拮抗剂疗法的年度用药成本及剂量增加率的差异。

Clin Ther. 2009 Apr;31(4):825-35. doi: 10.1016/j.clinthera.2009.04.002.

9

[Tumour necrosis factor alpha antagonists in established rheumatoid arthritis: effectiveness comparative study].[肿瘤坏死因子α拮抗剂用于确诊的类风湿性关节炎：有效性对比研究]

Med Clin (Barc). 2010 May 22;134(15):665-70. doi: 10.1016/j.medcli.2009.09.050. Epub 2010 Apr 2.

10

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.TNF-α 拮抗剂在类风湿关节炎中的生存情况：一项长期研究。

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):31-8. Epub 2012 Mar 6.

引用本文的文献

1

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis.类风湿关节炎中肿瘤坏死因子拮抗剂的药物生存率比较。

Patient Prefer Adherence. 2013 Jul 29;7:719-27. doi: 10.2147/PPA.S47453. eCollection 2013.